Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;27(11):2919-2922.
doi: 10.3201/eid2711.211886. Epub 2021 Sep 27.

Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021

Aharona Glatman-Freedman, Yael Hershkovitz, Zalman Kaufman, Rita Dichtiar, Lital Keinan-Boker, Michal Bromberg

Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021

Aharona Glatman-Freedman et al. Emerg Infect Dis. 2021 Nov.

Abstract

In Israel, the BNT162b2 vaccine against severe acute respiratory syndrome coronavirus 2 was approved for use in adolescents in June 2021, shortly before an outbreak of B.1.617.2 (Delta) variant-dominant infection. We evaluated short-term vaccine effectiveness and found the vaccine to be highly effective among this population in this setting.

Keywords: 2019 novel coronavirus disease; COVID-19; Delta variant; Israel; SARS-CoV-2; adolescents; coronavirus disease; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccine effectiveness; viruses; zoonoses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Vaccine doses among adolescents and total severe acute respiratory syndrome coronavirus 2 infections, Israel, June 1–August 26, 2021. A) Daily frequency of administration of first and second dose of BNT162b2 vaccine (Pfizer-BioNTech, https://www.pfizer.com) among adolescents 12–15 years of age. B) Daily cases of severe acute respiratory syndrome coronavirus 2 infection in persons of all ages.
Figure 2
Figure 2
Vaccine effectiveness against severe acute respiratory syndrome coronavirus 2 infection in adolescents 12–15 years of age, by time after second dose of BNT162b2 vaccine (Pfizer-BioNTech, https://www.pfizer.com), Israel, 2021. Error bars indicate 95% CIs.
See this image and copyright information in PMC

References

    1. Food and Drug Administration. Coronavirus (COVID-19) update: FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in adolescents in another important action in fight against pandemic [cited 2021 Aug 23]. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19...
    1. European Medicines Agency. First COVID-19 vaccine approved for children aged 12 to 15 in EU [cited 2021 Aug 23]. https://www.ema.europa.eu/en/news/first-covid-19-vaccine-approved-childr...
    1. Israel Ministry of Health. Ministry of Health's position regarding the expansion of the vaccination operation to ages 12–16 years [cited 2021 Aug 23]. https://www.gov.il/en/departments/news/02062021-01
    1. Israel Ministry of Health. Coronavirus outbreak in Binyamina [cited 2021 Aug 23]. https://www.gov.il/en/departments/news/19062021-02
    1. Israel Ministry of Health. Effective today (20.6.2021)—masking requirement at all schools in Modi’in and Binyamina [cited 2021 Aug 23]. https://www.gov.il/en/departments/news/20062021-01